086890 — ISU ABXIS Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for ISU ABXIS Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	25,607	28,018	41,170	54,306	60,258
Cost of Revenue
Gross Profit	11,321	11,034	13,149	35,382	43,347
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	39,219	38,254	56,467	50,419	67,772
Operating Profit	-13,612	-10,236	-15,297	3,886	-7,514
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-19,865	830	-7,247	3,712	-5,611
Provision for Income Taxes
Net Income After Taxes	-19,865	830	-7,247	3,611	14,718
Net Income Before Extraordinary Items
Net Income	-19,865	830	-7,247	3,611	14,718
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-19,865	830	-7,247	3,611	14,718
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-714	64.8	-241	104	793
Dividends per Share